9 min listen
E88: HCQ Dose Reductions and SLE Flares
E88: HCQ Dose Reductions and SLE Flares
ratings:
Length:
10 minutes
Released:
Oct 27, 2022
Format:
Podcast episode
Description
Interesting case-crossover study today evaluating the association between HCQ dosing and risk of SLE flares. Super worth your time to read the paper or listen to this episode!
https://jamanetwork.com/journals/jama/article-abstract/2796634
https://jamanetwork.com/journals/jama/article-abstract/2796634
Released:
Oct 27, 2022
Format:
Podcast episode
Titles in the series (87)
E6: Methylprednisolone and Cyclophosphamide, Alone or in Combinatinon, for Lupus Nephritis: Welcome back! Before we talk about cellcept for lupus nephritis, I decided we should flash back to 1996 and discuss one of the early trials that brought us cyclophosphamide. It's a quick discussion that will help set us up nicely for ALMS this Sunday. ... by The Evidence Based Rheumatology Podcast